129 related articles for article (PubMed ID: 15629461)
21. Analysis of beta-catenin aggregation and localization using GFP fusion proteins: nuclear import of alpha-catenin by the beta-catenin/Tcf complex.
Giannini AL; Vivanco MM; Kypta RM
Exp Cell Res; 2000 Mar; 255(2):207-20. PubMed ID: 10694436
[TBL] [Abstract][Full Text] [Related]
22. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of a zebrafish TCF ETS-domain transcription factor.
Brown LA; Yang SH; Hair A; Galanis A; Sharrocks AD
Oncogene; 1999 Dec; 18(56):7985-93. PubMed ID: 10637509
[TBL] [Abstract][Full Text] [Related]
24. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
Hu MC; Rosenblum ND
Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
[TBL] [Abstract][Full Text] [Related]
25. The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival.
Ioannidis V; Beermann F; Clevers H; Held W
Nat Immunol; 2001 Aug; 2(8):691-7. PubMed ID: 11477404
[TBL] [Abstract][Full Text] [Related]
26. "Decisions, decisions.": beta-catenin-mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells.
Wu L; Strasser A
Nat Immunol; 2001 Sep; 2(9):823-4. PubMed ID: 11526393
[No Abstract] [Full Text] [Related]
27. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
Park CH; Hahm ER; Park S; Kim HK; Yang CH
FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
[TBL] [Abstract][Full Text] [Related]
28. Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype.
Sekine S; Shibata T; Sakamoto M; Hirohashi S
Oncogene; 2002 Aug; 21(38):5906-11. PubMed ID: 12185590
[TBL] [Abstract][Full Text] [Related]
29. Thermodynamics of the high-affinity interaction of TCF4 with beta-catenin.
Knapp S; Zamai M; Volpi D; Nardese V; Avanzi N; Breton J; Plyte S; Flocco M; Marconi M; Isacchi A; Caiolfa VR
J Mol Biol; 2001 Mar; 306(5):1179-89. PubMed ID: 11237626
[TBL] [Abstract][Full Text] [Related]
30. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
[TBL] [Abstract][Full Text] [Related]
31. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
Rios-Doria J; Kuefer R; Ethier SP; Day ML
Cancer Res; 2004 Oct; 64(20):7237-40. PubMed ID: 15492240
[TBL] [Abstract][Full Text] [Related]
32. In vitro selection and characterization of TCF-1 binding RNA aptamers.
Lee SY; Jeong S
Mol Cells; 2004 Feb; 17(1):174-9. PubMed ID: 15055546
[TBL] [Abstract][Full Text] [Related]
33. The RNA aptamer disrupts protein-protein interaction between beta-catenin and nuclear factor-kappaB p50 and regulates the expression of C-reactive protein.
Choi YS; Hur J; Lee HK; Jeong S
FEBS Lett; 2009 May; 583(9):1415-21. PubMed ID: 19358846
[TBL] [Abstract][Full Text] [Related]
34. Direct metabolic regulation of beta-catenin activity by the p85alpha regulatory subunit of phosphoinositide 3-OH kinase.
Espada J; Peinado H; Esteller M; Cano A
Exp Cell Res; 2005 May; 305(2):409-17. PubMed ID: 15817165
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
[TBL] [Abstract][Full Text] [Related]
36. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
Hwang SG; Yu SS; Lee SW; Chun JS
FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
[TBL] [Abstract][Full Text] [Related]
37. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
Nateri AS; Spencer-Dene B; Behrens A
Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
[TBL] [Abstract][Full Text] [Related]
38. Requirement for a nuclear function of beta-catenin in Wnt signaling.
Cong F; Schweizer L; Chamorro M; Varmus H
Mol Cell Biol; 2003 Dec; 23(23):8462-70. PubMed ID: 14612392
[TBL] [Abstract][Full Text] [Related]
39. [beta-catenin overexpression in metastasized colorectal carcinoma--an important mechanism in progression of the disease?].
Mann B; Gratchev A; Riede E; Schmidt-Wolf I; Trojanek B; Moyer P; Hanski C; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):303-6. PubMed ID: 14518265
[TBL] [Abstract][Full Text] [Related]
40. ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules.
Daniels DL; Weis WI
Mol Cell; 2002 Sep; 10(3):573-84. PubMed ID: 12408825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
